These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 8331897)
1. Detection of MYCN gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections. Leong PK; Thorner P; Yeger H; Ng K; Zhang Z; Squire J Lab Invest; 1993 Jul; 69(1):43-50. PubMed ID: 8331897 [TBL] [Abstract][Full Text] [Related]
2. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Ambros PF; Ambros IM; Kerbl R; Luegmayr A; Rumpler S; Ladenstein R; Amann G; Kovar H; Horcher E; De Bernardi B; Michon J; Gadner H Med Pediatr Oncol; 2001 Jan; 36(1):1-4. PubMed ID: 11464855 [TBL] [Abstract][Full Text] [Related]
3. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore. Yong MH; Hwang WS; Knight LA; Fung W; Chan MY; Seow WT; Chui CH Singapore Med J; 2009 Nov; 50(11):1090-4. PubMed ID: 19960166 [TBL] [Abstract][Full Text] [Related]
4. Analysis of genomic imprinting at 1p35-36 in neuroblastoma. Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906 [TBL] [Abstract][Full Text] [Related]
5. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR. Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551 [TBL] [Abstract][Full Text] [Related]
6. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Maris JM; White PS; Beltinger CP; Sulman EP; Castleberry RP; Shuster JJ; Look AT; Brodeur GM Cancer Res; 1995 Oct; 55(20):4664-9. PubMed ID: 7553646 [TBL] [Abstract][Full Text] [Related]
7. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1. Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909 [TBL] [Abstract][Full Text] [Related]
8. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Gehring M; Berthold F; Edler L; Schwab M; Amler LC Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602 [TBL] [Abstract][Full Text] [Related]
9. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1. Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803 [TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190 [TBL] [Abstract][Full Text] [Related]
11. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome. Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859 [TBL] [Abstract][Full Text] [Related]
12. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping. Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192 [TBL] [Abstract][Full Text] [Related]
13. MYCN amplification and 17q in neuroblastoma: evidence for structural association. O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180 [TBL] [Abstract][Full Text] [Related]
14. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma. Spitz R; Hero B; Ernestus K; Berthold F Clin Cancer Res; 2003 Oct; 9(13):4835-40. PubMed ID: 14581355 [TBL] [Abstract][Full Text] [Related]
15. Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma. Hiyama E; Hiyama K; Yokoyama T; Fukuba I; Yamaoka H; Shay JW; Matsuura Y Clin Cancer Res; 1999 Mar; 5(3):601-9. PubMed ID: 10100712 [TBL] [Abstract][Full Text] [Related]
16. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma. Wimmer K; Zhu XX; Lamb BJ; Kuick R; Ambros P; Kovar H; Thoraval D; Elkahloun A; Meltzer P; Hanash SM Med Pediatr Oncol; 2001 Jan; 36(1):75-9. PubMed ID: 11464910 [TBL] [Abstract][Full Text] [Related]
17. Automatic quantification of gene amplification in clinical samples by IQ-FISH. Narath R; Lörch T; Rudas M; Ambros PF Cytometry B Clin Cytom; 2004 Jan; 57(1):15-22. PubMed ID: 14696059 [TBL] [Abstract][Full Text] [Related]
18. An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis. Spieker N; Beitsma M; van Sluis P; Roobeek I; den Dunnen JT; Speleman F; Caron H; Versteeg R Genes Chromosomes Cancer; 2000 Feb; 27(2):143-52. PubMed ID: 10612802 [TBL] [Abstract][Full Text] [Related]
19. Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q. Boensch M; Oberthuer A; Fischer M; Skowron M; Oestreich J; Berthold F; Spitz R Diagn Mol Pathol; 2005 Sep; 14(3):177-82. PubMed ID: 16106200 [TBL] [Abstract][Full Text] [Related]
20. [The neuroblastoma, "enfant terrible" among pediatric tumors]. Laureys G Verh K Acad Geneeskd Belg; 2003; 65(1):5-23; discussion 23-8. PubMed ID: 12802894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]